1813P Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 34; pp. S982 - S983
Main Authors	Laccetti, A.L., Chatta, G., Kyriakopoulos, C., Iannotti, N., Hotte, S.J., Markowski, M.C., Pili, R., Vuky, J., Zhang, J., Saad, F., Villaluna, K., Younginger, B., Le Moigne, R., Cesano, A.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.10.2023
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1016/j.annonc.2023.09.2761